文献速递主动脉疾病

Ovation Alto 覆膜支架的早期经验

Early Experience with Ovation Alto Stent-Graft.
PubMed 文献 · Ann Vasc Surg · 2022-09-01

BACKGROUND: Alto is the latest generation of the Ovation stent-graft platform for endovascular aneurysm repair (EVAR). Its ultra-low profile and its proximal sealing zone close to the lowest renal artery (≥7 mm) increase standard EVAR eligibility.…

要点

  • 7例EVAR均技术成功,完成造影无IA/IB/III型内漏。
  • 对照CTA见2例远端移位(≥2mm),无>10mm迁移。
  • 3例(42.8%)因低流量II型内漏接受严密监测。

核心结论

  • 早期经验显示Alto覆膜支架技术和临床成功前景良好,近端密封环上移和超低剖面输送系统使更广的主动脉解剖范围可按标签行EVAR。
  • 作者认为仍需进一步研究、Meta分析和前瞻性注册研究来评估该最新Ovation平台的中长期疗效和安全性。

研究设计与样本

  • 单中心病例系列,7例男性患者(平均年龄76.1±6.2岁)于2021年6月至2022年2月接受Ovation Alto覆膜支架EVAR。
  • 所有EVAR由对前代Ovation平台有经验的血管外科医生团队完成。
  • 随访包括术后1、3、6个月双功超声和1个月对照CTA。
  • 采用SPSS(版本25)和Excel进行描述性分析。

主要发现

  • 5例(71.4%)为梭形腹主动脉瘤,中位最大横径5.06 cm(范围3.98-6.99)。
  • 因不良主动脉瘤颈解剖,仅Ovation Alto覆膜支架被认为可按标签行EVAR;2例合并窄髂动脉(<6 mm)。
  • 对照CTA见2例远端移位(≥2mm),无远端迁移(>10mm)。
  • 随访中双功超声和CTA无I/III型内漏、无支架迁移(>10mm)、无近端主动脉瘤颈变化(P=无统计学显著性)。

关键数值与推荐

  • 近端密封区距最低肾动脉≥7 mm。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Alto is the latest generation of the Ovation stent-graft platform for endovascular aneurysm repair (EVAR). Its ultra-low profile and its proximal sealing zone close to the lowest renal artery (≥7 mm) increase standard EVAR eligibility. We report early clinical and technical outcomes with the Alto stent-graft in our University Hospital Center after CE Mark approval in August 2020. METHODS: Seven patients (all male, mean age 76.1 ± 6.2 years) underwent EVAR with Ovation Alto stent-graft between June 2021 and February 2022. All the EVAR procedures were performed by a team of vascular surgeons experienced on EVAR with previous generation of Ovation platform. Follow-up consisted of duplex ultrasound examination at 1, 3, and 6 months and of a 1-month control computed tomography angiography (CTA). Patients treated gave consent to participate in this case series and publication. A descriptive analysis of variables was performed. SPSS (version 25) and Excel were used for statistical analysis. RESULTS: Most of the patients had a fusiform abdominal aortic aneurysm (n = 5; 71.4%). The median maximal transversal aortic diameter was 5.06 cm (range, 3.98-6.99). Because of hostile aortic neck anatomy, on-label EVAR was considered feasible only with Ovation Alto stent-graft. Narrow iliac arteries (<6 mm) were also present in 2 cases. All procedures were performed according to the instruction for the use of the device. Technical success was achieved in all cases. No type IA/IB/III endoleak occurred at completion angiography. No distal migration (>10 mm) but 2 distal displacements (≥2 mm) were observed at control CTA. During follow-up, duplex ultrasound and CTA showed no type I/III endoleak, no stent-graft migration (>10 mm), and no proximal aortic neck variations (P = not statistically significant). Three patients (42.8%) are under strict surveillance because of low-flow type II endoleak not associated with sac variations. CONCLUSIONS: Our early experience shows promising technical and clinical success with Alto stent-graft. The proximal relocation of the proximal sealing rings and the ultra-low profile delivery system allow on-label EVAR in a wider range of aortic anatomies. Notwithstanding, further studies, meta-analysis, and prospective registries are mandatory to evaluate mid- and long-term efficacy and safety of this latest Ovation platform.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Cuozzo S, Martinelli O, Brizzi V, et al. Early Experience with Ovation Alto Stent-Graft. Ann Vasc Surg. 2022. PMID: 36058461. doi:10.1016/j.avsg.2022.07.030

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。